Cytiva supports Clover Biopharma to scale up output of COVID-19 vaccine candidate

US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...

November 17, 2020 | Tuesday | News
Australia unveils plans for new flu vaccine facility

The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...

November 16, 2020 | Monday | News
South Korea to host production of 150M Sputnik V doses for global distribution

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...

November 13, 2020 | Friday | News
Arcturus Therapeutics receives $220M from Singapore for COVID-19 vaccine development

Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...

November 12, 2020 | Thursday | News
COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...

November 10, 2020 | Tuesday | News
Australia secures further 50M doses of COVID-19 vaccine

Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...

November 5, 2020 | Thursday | News
Australia reports highest childhood vaccination rates in 2020

On 1 Nov 2020, Australia reported the highest recorded childhood vaccination, with new figures showing four quarters of ...

November 2, 2020 | Monday | News
Takeda expands COVID-19 vaccine supply in Japan

Takeda Pharmaceutical has announced that it will import and distribute 50 million doses of Moderna’s COVID-19...

October 30, 2020 | Friday | News
Moderna announces COVID-19 vaccine supply agreement with Qatar

Moderna Inc. has announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moder...

October 29, 2020 | Thursday | News
Russia applies to WHO for vaccine prequalification of Sputnik V

The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to...

October 28, 2020 | Wednesday | News
Japan pledges $130M to support global access to COVID-19 vaccines

The global effort to ensure equitable global access to COVID-19 vaccines received a boost with the announcement of a maj...

October 21, 2020 | Wednesday | News
BioNTech, Pfizer to initiate Ph 1/2 trial of COVID-19 mRNA vaccine candidate in Japan

Pfizer Inc. and BioNTech SE on 21 Oct 2020 announced the start of a Phase 1/2 study in Japan for their BN...

October 21, 2020 | Wednesday | News
Thailand triggers production of COVID-19 vaccine for 2021

Thailand Ministry of Public Health, Siam Bioscience, SCG and British-Swedish biopharmaceutical company AstraZeneca has s...

October 19, 2020 | Monday | News
Taiwan inks deal with BioNTech for COVID-19 vaccine delivery

Taiwan based TTY Biopharm Company, has announced that it has received authorization for the delivery of coronavirus vacc...

October 13, 2020 | Tuesday | News
SII to produce 200 million COVID-19 vaccines doses for India and LMICs in 2021

A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volu...

October 9, 2020 | Friday | News
EU secures 400 million doses of Janssen’s COVID-19 Vaccine Candidate

  Johnson & Johnson on 8 Oct 2020 announced that the European Commission (EC), acting on behalf of the Europea...

October 9, 2020 | Friday | News
CEPI establishes global centralized COVID-19 vaccine candidates assessment network

The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has announced partnerships with five clinical sampl...

October 8, 2020 | Thursday | News
Australia invests $2.3 B on native COVID-19 vaccine

The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to de...

October 8, 2020 | Thursday | News